Effects of airway exposure to di-(2-ethylhexyl) phthalate on allergic rhinitis

Immunopharmacology and Immunotoxicology

Volumn 35, Issue 3, 2013, Pages 390-395

  He, Miao ^a,b   Inoue, Ken Ichiro ^c   Yoshida, Seiichi ^a   Tanaka, Michitaka ^c   Takano, Hirohisa ^d   Sun, Guifan ^b   Ichinose, Takamichi ^a  

^a OITA UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Allergic rhinitis; Cytokine; Di (2 ethylhexyl) phthalate; Neutrophils; Ovalbumin

Indexed keywords

ALLERGEN; CHEMOATTRACTANT; EOTAXIN; INTERLEUKIN 13; INTERLEUKIN 6; OVALBUMIN; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER;

AIRWAY; ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; EOSINOPHIL; FEMALE; GRANULOCYTE; HISTOPATHOLOGY; KERATINOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; NOSE CAVITY; PRIORITY JOURNAL;

AIR POLLUTANTS; ANIMALS; CYTOKINES; DIETHYLHEXYL PHTHALATE; FEMALE; INHALATION EXPOSURE; LEUKOCYTE COUNT; MICE; MICE, INBRED BALB C; NASAL CAVITY; NASAL LAVAGE FLUID; NEUTROPHIL INFILTRATION; NEUTROPHILS; OVALBUMIN; RHINITIS, ALLERGIC, PERENNIAL;

EID: 84877863267     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2013.787432     Document Type: Article

References (23)

1. Beasley R, Ellwood P, Asher, I. International patterns of the prevalence of pediatric asthma the ISAAC program. Pediatr Clin North Am 2003;50:539-53
2. Takahashi, K. Chemical contamination of the environment and development of allergic and autoimmune diseases. Nihon Rinsho 2010;68:551-62
3. Kolarik B, Naydenov K, Larsson M, et al. The association between phthalates in dust and allergic diseases among Bulgarian children. Environ Health Perspect 2008;116:98-103
4. Bornehag CG, Sundell J, Weschler CJ, et al. The association between asthma and allergic symptoms in children and phthalates in house dust: a nested case-control study. Environ Health Perspect 2004;112:1393-7
5. Takano H, Yanagisawa R, Inoue K, et al. Di-(2-ethylhexyl) phthalate enhances atopic dermatitis-like skin lesions in mice. Environ Health Perspect 2006;114:1266-9
6. Larsen ST, Hansen JS, Hansen EW, et al. Airway inflammation and adjuvant effect after repeated airborne exposures to di-(2- ethylhexyl)phthalate and ovalbumin in BALB/c mice. Toxicology 2007;235:119-29
7. Larsen ST, Nielsen GD. The adjuvant effect of di-(2-ethylhexyl) phthalate is mediated through a PPARalpha-independent mechanism. Toxicol Lett 2007;170:223-8
8. Tanaka M, Inoue K, Momoi T, Takano H. In vivo immunoamplifying effects of di-(2-ethylhexyl) phthalate on cytokine response. Immunopharmacol Immunotoxicol 2013;35:147-50
9. Potera, C. Autoimmune disease: phthalate linked to lupus in mice. Environ Health Perspect 2005;113:A809
10. Strachan D, Sibbald B, Weiland S, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997;8:161-76
11. Malone DC, Lawson KA, Smith DH, et al. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol 1997; 99:22-7
12. Kim SY, Yoon SJ, Jo MW, et al. Economic burden of allergic rhinitis in Korea. Am J Rhinol Allergy 2010;24:e110-13
13. Kobayashi T. Exposure to diesel exhaust aggravates nasal allergic reaction in guinea pigs. Am J Respir Crit Care Med 2000;162: 352-6
14. Minty A, Chalon P, Derocq JM, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993;362:248-50
15. Zurawski G, de Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994;15:19-26
16. Defrance T, Carayon P, Billian G, et al. Interleukin 13 is a B cell stimulating factor. J Exp Med 1994;179:135-43
17. McKenzie GJ, Emson CL, Bell SE, et al. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 1998;9:423-32
18. Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-61
19. Zhu Z, Homer RJ, Wang Z, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779-88
20. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev 2004;202:175-90
21. Pawankar RU, Okuda M, Hasegawa S, et al. Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis. Am J Respir Crit Care Med 1995;152:2059-67
22. Ghaffar O, Laberge S, Jacobson MR, et al. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL- 4 expression and modulation by topical glucocorticoid therapy. Am J Respir Cell Mol Biol 1997;17:17-24
23. Miyahara S, Miyahara N, Matsubara S, et al. IL-13 is essential to the late-phase response in allergic rhinitis. J Allergy Clin Immunol 2006;118:1110-16